These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17975003)

  • 21. Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.
    Kok M; Koornstra RH; Margarido TC; Fles R; Armstrong NJ; Linn SC; Van't Veer LJ; Weigelt B
    J Pathol; 2009 Jul; 218(3):316-26. PubMed ID: 19353633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis.
    Hess-Wilson JK; Boldison J; Weaver KE; Knudsen KE
    Breast Cancer Res Treat; 2006 Apr; 96(3):279-92. PubMed ID: 16328721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of a gene expression profile on breast cancer decisions.
    Henry LR; Stojadinovic A; Swain SM; Prindiville S; Cordes R; Soballe PW
    J Surg Oncol; 2009 May; 99(6):319-23. PubMed ID: 19204954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting features of breast cancer with gene expression patterns.
    Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
    Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer.
    Barnett DH; Sheng S; Charn TH; Waheed A; Sly WS; Lin CY; Liu ET; Katzenellenbogen BS
    Cancer Res; 2008 May; 68(9):3505-15. PubMed ID: 18451179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
    Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth.
    Sartorius CA; Harvell DM; Shen T; Horwitz KB
    Cancer Res; 2005 Nov; 65(21):9779-88. PubMed ID: 16266999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogenic regulation of host immunity against an estrogen receptor-negative human breast cancer.
    Curran EM; Judy BM; Duru NA; Wang HQ; Vergara LA; Lubahn DB; Estes DM
    Clin Cancer Res; 2006 Oct; 12(19):5641-7. PubMed ID: 17000652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.
    Santen R; Cavalieri E; Rogan E; Russo J; Guttenplan J; Ingle J; Yue W
    Ann N Y Acad Sci; 2009 Feb; 1155():132-40. PubMed ID: 19250200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptation of estrogen-regulated genes in long-term estradiol deprived MCF-7 breast cancer cells.
    Santen RJ; Lobenhofer EK; Afshari CA; Bao Y; Song RX
    Breast Cancer Res Treat; 2005 Dec; 94(3):213-23. PubMed ID: 16258703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of the receptor content and growth fraction of breast cancers and their axillary lymph node metastases].
    Fleige B; Pickartz H; Stein H
    Pathologe; 1989 Jan; 10(1):12-5. PubMed ID: 2646629
    [No Abstract]   [Full Text] [Related]  

  • 35. Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers?
    Sheikh MS; Garcia M; Pujol P; Fontana JA; Rochefort H
    Invasion Metastasis; 1994-1995; 14(1-6):329-36. PubMed ID: 7657526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer.
    Gomez-Fernandez C; Daneshbod Y; Nassiri M; Milikowski C; Alvarez C; Nadji M
    Am J Clin Pathol; 2008 Dec; 130(6):879-82. PubMed ID: 19019763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells.
    Zheng ZY; Zheng SM; Bay BH; Aw SE; C-L Lin V
    Breast Cancer Res Treat; 2008 Jul; 110(1):111-25. PubMed ID: 17687644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures.
    Zhu Y; Wang A; Liu MC; Zwart A; Lee RY; Gallagher A; Wang Y; Miller WR; Dixon JM; Clarke R
    Int J Oncol; 2006 Dec; 29(6):1581-9. PubMed ID: 17089000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study.
    Wolf I; Ben-Baruch N; Shapira-Frommer R; Rizel S; Goldberg H; Yaal-Hahoshen N; Klein B; Geffen DB; Kaufman B
    Cancer; 2008 Feb; 112(4):731-6. PubMed ID: 18076012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of intratumoral estrone (E1) and estradiol (E2) in primary breast cancer tissues by sensitive HPLC-RIA].
    Nagaya N; Toi M; Sunahara S; Kurimoto F; Tominaga T
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):329-36. PubMed ID: 9051136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.